Enzon Pharmaceuticals, Inc.'s PEG-SN38 Featured in Clinical Cancer Research

March 17, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that PEG-SN38 is featured in the March 15th issue of Clinical Cancer Research published by the American Association for Cancer Research, Inc. (AACR).

Twitter
LinkedIn
Facebook
Email
Print